European Case Law Identifier: | ECLI:EP:BA:2003:T055200.20031030 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 30 October 2003 | ||||||||
Case number: | T 0552/00 | ||||||||
Application number: | 94911894.7 | ||||||||
IPC class: | A61K 39/39 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Vaccine compositions containing 3-0 deacylated monophosphoryl lipid A | ||||||||
Applicant name: | SMITHKLINE BEECHAM BIOLOGICALS S.A. | ||||||||
Opponent name: | Wyeth Holdings Corporation | ||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: | |||||||||
Keywords: | Late submission - admitted Added subject-matter - main request - (no) Extension of protection - main request - (no) Priority right - main request - (yes) Novelty - main request - (yes) Inventive step - main request - (yes) |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t000552eu1.html
Date retrieved: 17 May 2021